Abstract
Purpose of Review
Surveillance imaging improves survival in women with a personal history of breast cancer (PHBC); however, imaging strategies vary in this population. This review evaluated current literature and guidelines regarding imaging modalities and approaches in women with PHBC.
Recent Findings
The consensus among major breast societies is that annual surveillance mammography is recommended in all women with PHBC. Noting limitations of mammography, supplemental imaging modalities have emerged and are increasingly utilized by practices, providing the benefit of incremental cancer detection at the expense of potential additional false-positive workups.
Summary
Annual surveillance mammography is associated with improved outcomes among women with PHBC. Accurate risk assessment and careful patient selection are needed when considering supplemental imaging, in order to maximize benefits, limit false-positive workups, and appropriately utilize limited resources.
Similar content being viewed by others
Data Availability
Not applicable.
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
•• Lawson MB, Herschorn SD, Sprague BL, Buist DSM, Lee S-J, Newell MS, et al. Imaging surveillance options for individuals with a personal history of breast cancer: AJR expert panel narrative review. AJR Am J Roentgenol. 2022;219(6):854–68. https://doi.org/10.2214/AJR.22.27635. This thorough review of imaging in women with prior breast cancers provides a risk-based stratification approach that could be utilized to improve shared decision-making when selecting a supplemental imaging modality.
Lee JM, Buist DSM, Houssami N, Dowling EC, Halpern EF, Gazelle GS, et al. Five-year risk for interval-invasive second breast cancer. J Natl Cancer Inst. 2015;107(7):109. https://doi.org/10.1093/jnci/djv109.
Buist DSM, Abraham LA, Barlow WE, Krishnaraj A, Holdridge RC, Sickles EA, et al. Diagnosis of second breast cancer events after initial diagnosis of early stage breast cancer. Breast Cancer Res Treat. 2010;124(3):863–73. https://doi.org/10.1007/s10549-010-1106-6.
Lam DL, Houssami N, Lee JM. Imaging surveillance after primary breast cancer treatment. AJR Am J Roentgenol. 2017;208(3):676–86. https://doi.org/10.2214/AJR.16.16300.
Gunia SR, Merrigan TL, Poulton TB, Mamounas EP. Evaluation of appropriate short-term mammographic surveillance in patients who undergo breast-conserving surgery (BCS). Ann Surg Oncol. 2012;19(10):3139–43. https://doi.org/10.1245/s10434-012-2578-x.
Kokko R, Hakama M, Holli K. Follow-up cost of breast cancer patients with localized disease after primary treatment: a randomized trial. Breast Cancer Res Treat. 2005;93(3):255–60. https://doi.org/10.1007/s10549-005-5199-2.
Gradishar WJ, Moran MS, Abraham J, Abramson V, Aft R, Agnese D, et al. NCCN guidelines: breast cancer, version 4.2023. Natl Compr Cancer Net. 2023;21(6):594–608.
Mehta TS, Lourenco AP, Niell BL, Bennett DL, Brown A, Chetlen A, et al. ACR appropriateness criteria: imaging after breast surgery. J Am Coll Radiol. 2022;19(11S):S341–56. https://doi.org/10.1016/j.jacr.2022.09.003.
Runowicz CD, Leach CR, Henry NL, Henry KS, Mackey HT, Cowens-Alvarado RL, et al. American Cancer Society/American Society of Clinical Oncology breast cancer survivorship care guideline. CA Cancer J Clin. 2016;34(6):611–35. https://doi.org/10.3322/caac.21319.
The American Society of Breast Surgeons: position statement on screening mammography. Available at https://www.breastsurgeons.org/docs/statements/Position-Statement-on-Screening-Mammography.pdf. Accessed on 7 Mar 2023.
Mammograms After Breast Cancer Surgery. Available at https://www.cancer.org/cancer/breast-cancer/screening-tests-and-early-detection/mammograms/having-a-mammogram-after-youve-had-breast-cancer-surgery.html. Accessed on 7 Mar 2023.
Bahl M, Mercaldo S, McCarthy AM, Lehman CD. Imaging surveillance of breast cancer survivors with digital mammography versus digital breast tomosynthesis. Radiology. 2021;298(2):308–16. https://doi.org/10.1148/radiol.2020201854.
Osman NM, Ghany EA, Chalabi N. The added benefit of digital breast tomosynthesis in second breast cancer detection among treated breast cancer patients. Egypt J Radiol Nucl Med. 2018;49(4):1182–6. https://doi.org/10.1016/j.ejrnm.2018.07.007.
• Yoon JH, Kim EK, Kim GR, Han K, Moon HJ. Mammographic surveillance after breast-conserving therapy: impact of digital breast tomosynthesis and artificial intelligence–based computer-aided detection. AJR Am J Roentgenol. 2022;218(1):42–51. https://doi.org/10.2214/AJR.21.26506. This study evaluated the role of AI in postoperative mammograms and found that it led to improved accuracy and reduced recall rates compared to digital mammography alone.
Patel BK, Lee CS, Kosiorek HE, Newell MS, Pizzitola VJ, D’Orsi CJ. Variability of postsurgical imaging surveillance of breast cancer patients: a nationwide survey study. AJR Am J Roentgenol. 2018;210(1):222–7. https://doi.org/10.2214/AJR.17.17923.
Nguyen DL, Liang A, Mullen LA, Oluyemi E, Myers KS, Panigrahi B, et al. Diagnostic versus screening mammography recommendations for postlumpectomy imaging surveillance of patients with breast cancer. AJR Am J Roentgenol. 2021;217(5):1081–2. https://doi.org/10.2214/AJR.20.25417.
Bychkovsky BL, Lin NU. Imaging in the evaluation and follow-up of early and advanced breast cancer: when, why, and how often? Breast. 2017;31:318–24. https://doi.org/10.1016/j.breast.2016.06.017.
Smith D, Sepehr S, Karakatsanis A, Strand F, Valachis A. Yield of surveillance imaging after mastectomy with or without reconstruction for patients with prior breast cancer: a systematic review and meta-analysis. JAMA Netw Open. 2022;5(12):e2244212. https://doi.org/10.1001/jamanetworkopen.2022.44212.
Freyvogel M, Padia S, Larson K, Dietz J, Grobmyer S, O’Rourke C, et al. Screening mammography following autologous breast reconstruction: an unnecessary effort. Ann Surg Oncol. 2014;21(10):3256–60. https://doi.org/10.1245/s10434-014-3913-1.
Noroozian M, Carlson LW, Savage JL, Jeffries DO, Joe AI, Neal CH, et al. Use of screening mammography to detect occult malignancy in autologous breast reconstructions: a 15-year experience. Radiology. 2018;289(1):39–48. https://doi.org/10.1148/radiol.2018172783.
Gradishar WJ, Moran MS, Abraham J, Abramson V, Aft R, Agnese D, et al. NCCN guidelines: breast cancer, version 4.2023. National Comprehensive Cancer Network. 2023:226.
Heller SL, Lourenco AP, Niell BL, Ajkay N, Brown A, Dibble EH, et al. ACR appropriateness criteria: imaging after mastectomy and breast reconstruction. J Am Coll Radiol. 2020;17(11S):S403–14. https://doi.org/10.1016/j.jacr.2020.09.009.
Lee JM, Ichikawa LE, Wernli KJ, Bowles E, Specht JM, Kerlikowske K, et al. Digital mammography and breast tomosynthesis performance in women with a personal history of breast cancer, 2007–2016. Radiology. 2021;300(2):290–300. https://doi.org/10.1148/radiol.2021204581.
Gweon HM, Cho N, Han W, Yi A, Moon HG, Noh DY, et al. Breast MR imaging screening in women with a history of breast conservation therapy. Radiology. 2014;272(2):366–73. https://doi.org/10.1148/radiol.14131893.
Cho N, Han W, Han BK, Bae MS, Ko ES, Nam SJ, et al. Breast cancer screening with mammography plus ultrasonography or magnetic resonance imaging in women 50 years or younger at diagnosis and treated with breast conservation therapy. JAMA Oncol. 2017;3(11):1495–502. https://doi.org/10.1001/jamaoncol.2017.1256.
Wernli KJ, Ichikawa L, Kerlikowske K, Buist DSM, Brandzel SD, Bush M, et al. Surveillance breast MRI and mammography: comparison in women with a personal history of breast cancer. Radiology. 2019;292(2):311–8. https://doi.org/10.1148/radiol.2019182475.
Buist DSM, Abraham L, Lee CI, Lee JM, Lehman C, O’Meara ES, et al. Breast biopsy intensity and findings following breast cancer screening in women with and without a personal history of breast cancer. JAMA Intern Med. 2018;178(4):458–68. https://doi.org/10.1001/jamainternmed.2017.8549.
•• Monticciolo DL, Newell MS, Moy L, Niell B, Monsees B, Sickles EA. Breast cancer screening in women at higher-than-average risk: recommendations from the ACR. J Am Coll Radiol. 2018;15(3):408–14. https://doi.org/10.1016/j.jacr.2017.11.034. This article summarizes the imaging recommendations for women at higher-than-average risk of breast cancer, including the expansion of supplemental surveillance MRI to women with PHBC who have dense breasts or were diagnosed with breast cancer before age 50.
• Comstock CE, Gatsonis C, Newstead GM, Snyder BS, Gareen IF, Bergin JT, et al. Comparison of abbreviated breast MRI vs digital breast tomosynthesis for breast cancer detection among women with dense breasts undergoing screening. JAMA. 2020;323(8):746–56. https://doi.org/10.1001/jama.2020.0572. This multi-center, cross-sectional longitudinal study evaluating screening in women with dense breasts found that abbreviated MRI was associated with a significantly higher detection of invasive breast cancer compared to DBT.
Park KW, Han SB, Han BK, Ko ES, Choi JS, Rhee SJ, et al. MRI surveillance for women with a personal history of breast cancer: comparison between abbreviated and full diagnostic protocol. Br J Radiol. 2020;93(1106):20190733. https://doi.org/10.1259/bjr.20190733.
• Kim SY, Cho N, Hong H, Lee Y, Yoen H, Kim YS, et al. Abbreviated screening MRI for women with a history of breast cancer: comparison with full-protocol breast MRI. Radiology. 2022;305(1):36–45. https://doi.org/10.1148/radiol.213310. This propensity score-matched, single-center, retrospective cohort study found that abbreviated MRI was associated with comparable sensitivity and superior specificity compared to full-protocol MRI.
Song SE, Cho N, Chang JM, Chu AJ, Yi A, Moon WK. Diagnostic performances of supplemental breast ultrasound screening in women with personal history of breast cancer. Acta Radiol. 2018;59(5):533–9. https://doi.org/10.1177/0284185117725779.
Kim SY, Cho N, Kim SY, Choi Y, Kim ES, Ha SM, et al. Supplemental breast US screening in women with a personal history of breast cancer: a matched cohort study. Radiology. 2020;295(1):54–63. https://doi.org/10.1148/radiol.2020191691.
Berg WA, Zhang Z, Lehrer D, Jong RA, Pisano ED, Barr RG, et al. Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. JAMA. 2012;307(13):1394–404. https://doi.org/10.1001/jama.2012.388.
Gluskin J, Rossi Saccarelli C, Avendano D, Marino MA, Bitencourt AGV, Pilewskie M, et al. Contrast-enhanced mammography for screening women after breast conserving surgery. Cancers. 2020;12(12):3495. https://doi.org/10.3390/cancers12123495.
Sorin V, Yagil Y, Yosepovich A, Shalmon A, Gotlieb M, Neiman OH, et al. Contrast-enhanced spectral mammography in women with intermediate breast cancer risk and dense breasts. AJR Am J Roentgenol. 2018;211(5):W267–74. https://doi.org/10.2214/AJR.17.19355.
Jochelson MS, Lobbes MBI. Contrast-enhanced mammography: state of the art. Radiology. 2021;299(1):36–48. https://doi.org/10.1148/radiol.2021201948.
Rhodes DJ, Hruska CB, Conners AL, Tortorelli CL, Maxwell RW, Jones KN, et al. Molecular breast imaging at reduced radiation dose for supplemental screening in mammographically dense breasts. AJR Am J Roentgenol. 2015;204(2):241–51. https://doi.org/10.2214/AJR.14.13357.
Author information
Authors and Affiliations
Contributions
A.T. drafted the original manuscript. S.M. edited and supplemented the original manuscript. All authors reviewed the manuscript.
Corresponding author
Ethics declarations
Ethical Approval
Not applicable.
Conflict of Interest
The authors declare no competing interests.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Tavana, A., Maimone, S. Posttreatment Breast Imaging Considerations. Curr Breast Cancer Rep 15, 337–344 (2023). https://doi.org/10.1007/s12609-023-00511-4
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12609-023-00511-4